Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Verapamil leaves plasma lipids unchanged post-MI; confirms neutral lipoprotein effects in secondary prevention.
The effect of verapamil on plasma lipids and lipoproteins was studied in 64 patients taking part in a double blind controlled trial of verapamil versus placebo in post myocardial infarction. During a six month treatment period no significant difference was seen in plasma cholesterol, triglycerides, high density lipoproteins or low density lipoproteins.
No takes yet. Share an insight, caveat, or question.
Strunge et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: